Showing results (41-50 of 60) with videos related to
Sort By:
Pageof 6
Reviews on Recent Clinical Trials|June 1, 2022
Satisfaction in Social Roles and Physical Function in Immune-mediated Inflammatory Diseases: A Cross-Sectional StudyRocco Spagnuolo, Francesco Salvatore Iaquinta, Daniele Mauro, et al.Pharmaceutics|November 11, 2022
Real-World Safety Profile of Biologics Used in Rheumatology: A Six-Year Observational Pharmacovigilance Study in the Calabria RegionAgnese Gagliardi, Francesco Salvatore Iaquinta, Rosa Daniela Grembiale, et al.Arthritis Research & Therapy|June 24, 2020
Parenchymal lung disease in adult onset Still's disease: an emergent marker of disease severity-characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patientsPiero Ruscitti, Onorina Berardicurti, Daniela Iacono, et al.Journal of Immunology Research|July 6, 2026
Novel Biomarker for Antimitochondrial Antibodies in Systemic Sclerosis PatientsElvira Favoino, Silvia De Santis, Vasiliki Liakouli, et al.Plos One|October 26, 2018
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP)Caterina Palleria, Luigi Iannone, Christian Leporini, et al.Clinical and Experimental Rheumatology|April 4, 2025
Primary versus systemic-sclerosis-associated Raynaud's phenomenon: relationship with clinical and environmental factorsElvira Favoino, Marcella Prete, Vasiliki Liakouli, et al.Clinical and Experimental Rheumatology|December 18, 2020
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational studyPiero Ruscitti, Paola Cipriani, Vasiliki Liakouli, et al.RMD Open|May 21, 2026
Real-world damage accrual in Sjögren's disease: a 5-year multicentre GIRRCS cohort analysisOnorina Berardicurti, Annalisa Marino, Luca Navarini, et al.Arthritis Research & Therapy|September 5, 2019
Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) studyPiero Ruscitti, Paola Cipriani, Vasiliki Liakouli, et al.Clinical and Experimental Rheumatology|January 11, 2021
Quality of life and therapeutic management of axial spondyloarthritis patients in Italy: a 12-month prospective observational studySalvatore D'Angelo, Nazzarena Malavolta, Cinzia Scambi, et al.Pageof 6